Loading stock analysis…
Evidence Synthesis
Last synthesized: 20 Oct 2026, 09:43
See how this stock's evidence score moved across recent sessions — unlock Pro for the live chart.
Full momentum history unlocks with Pro or Research.
Evidence velocity
Rate-of-change signals for this ticker unlock with Pro — or view flagship demos TCS / RELIANCE.
Evidence Synthesis
RAPIDIN's 100% accelerated to, up from 23.05%.
The company's .05% also accelerated, up from .33%. Revenue growth accelerated, moving from -90.5% to .9%. Daily trading volume increased, rising from 25 shares to .
Source observations behind the synthesis narrative.
| Metric | Value | Trend | |
|---|---|---|---|
| GROSS_MARGIN | 100 % | 23.05 | ▲ |
| MARGINAL_OPERATING_LEVERAGE | 23.05 % | 7.33 | ▲ |
| REVENUE_GROWTH_YOY | 25.9 % | -90.5 | ▲ |
| PRICE_CHANGE_PERCENT | 0 % | — | - |
| DAILY_VOLUME | 45 shares | 25 | ▲ |
| CLOSE_PRICE | 85 INR | 85 | - |
Cite this
Source: Samhati evidence synthesis for RAPIDIN (2026-10-20). Observation: RAPIDIN's 100% accelerated to, up from 23.05%. Evidence quality: medium. Not investment advice — no buy, sell, or hold recommendation. Full narrative (Pro): https://samhati.ai/pricing Page: https://samhati.ai/stock/rapidin
Filing step-changes